SGMT
Sagimet Biosciences Inc. Series A
9.20$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.9% | 99.9% | 100.0% | 88.2% | 89.9% | 95.3% | 99.9% | 92.6% | 92.9% | 99.9% | 100.0% | 92.6% | |
| 98.9% | 77.7% | 90.9% | 50.8% | 44.1% | 47.3% | 44.3% | 30.8% | 25.3% | 30.1% | 34.0% | 63.0% | |
| 98.9% | 98.1% | 99.6% | 88.0% | 87.2% | 94.4% | 98.9% | 91.3% | 90.9% | 97.1% | 97.0% | 91.2% | |
| 4.9% | 5.8% | 2.3% | 3.0% | 2.3% | 2.8% | 4.9% | 5.3% | 7.1% | 4.4% | 4.9% | 2.8% | |
| 4.9% | 5.8% | 2.3% | 3.0% | 2.3% | 2.8% | 4.9% | 5.3% | 7.1% | 4.4% | 4.9% | 2.1% | |
| 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | |
| 1.7% | 0.2% | 0.3% | 1.1% | 0.7% | 0.9% | 2.2% | 1.4% | 3.3% | 1.1% | 2.1% | 0.4% | |
| 95.1% | 94.2% | 97.7% | 97.0% | 97.7% | 97.2% | 95.1% | 94.7% | 92.9% | 95.6% | 95.1% | 97.2% | |
| -234.7% | -258.2% | -131.8% | -139.9% | -159.7% | -184.3% | -214.5% | -235.7% | -262.3% | -297.3% | -331.3% | -140.8% | |
| 17.7% | 18.8% | 14.9% | 16.9% | 18.4% | 20.1% | 22.0% | 23.4% | 25.3% | 27.9% | 30.2% | 20.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.